| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial resistance dynamics of Listeria monocytogenes in France: where we are and what we need?
|
Ed-Dra, Abdelaziz
|
|
|
37 |
C |
p.
|
artikel
|
| 2 |
Atrial fibrillation: better symptom control with rate and rhythm management
|
Gupta, Dhiraj
|
|
|
37 |
C |
p.
|
artikel
|
| 3 |
Atrial fibrillation: comorbidities, lifestyle, and patient factors
|
Shantsila, Eduard
|
|
|
37 |
C |
p.
|
artikel
|
| 4 |
Atrial fibrillation: epidemiology, screening and digital health
|
Linz, Dominik
|
|
|
37 |
C |
p.
|
artikel
|
| 5 |
Atrial fibrillation: pathophysiology, genetic and epigenetic mechanisms
|
Vinciguerra, Manlio
|
|
|
37 |
C |
p.
|
artikel
|
| 6 |
Atrial fibrillation: stroke prevention
|
Chao, Tze-Fan
|
|
|
37 |
C |
p.
|
artikel
|
| 7 |
Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial
|
Lopategui, Diana M.
|
|
|
37 |
C |
p.
|
artikel
|
| 8 |
Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial—authors’ reply
|
Sapoval, Marc
|
|
|
37 |
C |
p.
|
artikel
|
| 9 |
Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial
|
Sager, Petra
|
|
|
37 |
C |
p.
|
artikel
|
| 10 |
Efficacy and safety of onasemnogene abeparvovec in children with spinal muscular atrophy type 1: real-world evidence from 6 infusion centres in the United Kingdom
|
Gowda, Vasantha
|
|
|
37 |
C |
p.
|
artikel
|
| 11 |
European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study
|
Eriksson, Mikael
|
|
|
37 |
C |
p.
|
artikel
|
| 12 |
Gene replacement therapy in spinal muscular atrophy: filling the data gaps
|
Hagenacker, Tim
|
|
|
37 |
C |
p.
|
artikel
|
| 13 |
Moderated intake of carbohydrates has moderate glycaemic benefits in type 1 diabetes
|
Schmidt, Signe
|
|
|
37 |
C |
p.
|
artikel
|
| 14 |
Monitoring progress towards universal health coverage in Europe: a descriptive analysis of financial protection in 40 countries
|
Thomson, Sarah
|
|
|
37 |
C |
p.
|
artikel
|
| 15 |
Phenotypic and genotypic antimicrobial resistance of Listeria monocytogenes: an observational study in France
|
Moura, Alexandra
|
|
|
37 |
C |
p.
|
artikel
|
| 16 |
Pneumococcal serotypes and risk factors in adult community acquired pneumonia 2018–20: a multicentre UK cohort study
|
Lansbury, Louise
|
|
|
37 |
C |
p.
|
artikel
|
| 17 |
Rare diseases: still on the fringes of universal health coverage in Europe
|
Tumienė, Birutė
|
|
|
37 |
C |
p.
|
artikel
|
| 18 |
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
|
Bedston, Stuart
|
|
|
37 |
C |
p.
|
artikel
|
| 19 |
Semaglutide and beyond: a turning point in obesity pharmacotherapy
|
The Lancet Regional Health – Europe,
|
|
|
37 |
C |
p.
|
artikel
|
| 20 |
Stroke prevention and symptom control in atrial fibrillation—handling a global and major health crisis
|
Brandes, Axel
|
|
|
37 |
C |
p.
|
artikel
|
| 21 |
Tackling a growing healthcare challenge: atrial fibrillation epidemiology, prevention, and underlying causes
|
Vad, Oliver B.
|
|
|
37 |
C |
p.
|
artikel
|
| 22 |
Thank you to The Lancet Regional Health - Europe’s clinical and statistical peer reviewers in 2023
|
|
|
|
37 |
C |
p.
|
artikel
|
| 23 |
The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial
|
Sterner Isaksson, Sofia
|
|
|
37 |
C |
p.
|
artikel
|
| 24 |
Urgent health update: rising measles cases in Kazakhstan
|
Akilbekova, Dana
|
|
|
37 |
C |
p.
|
artikel
|
Tijdschrift beschrijving